These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. A phosphate-centric paradigm for pathophysiology and therapy of chronic kidney disease. Kuro-O M Kidney Int Suppl (2011); 2013 Dec; 3(5):420-426. PubMed ID: 25019024 [TBL] [Abstract][Full Text] [Related]
46. Integral pharmacological management of bone mineral disorders in chronic kidney disease (part I): from treatment of phosphate imbalance to control of PTH and prevention of progression of cardiovascular calcification. Bover J; Ureña-Torres P; Lloret MJ; Ruiz-García C; DaSilva I; Diaz-Encarnacion MM; Mercado C; Mateu S; Fernández E; Ballarin J Expert Opin Pharmacother; 2016 Jun; 17(9):1247-58. PubMed ID: 27156993 [TBL] [Abstract][Full Text] [Related]
47. Klotho and endocrine fibroblast growth factors: markers of chronic kidney disease progression and cardiovascular complications? Kuro-O M Nephrol Dial Transplant; 2019 Jan; 34(1):15-21. PubMed ID: 29800324 [TBL] [Abstract][Full Text] [Related]
48. Reconsidering the role of albumin towards amorphous calcium phosphate-based calciprotein particles formation and stability from a physico-chemical perspective. Gelli R; Ridi F Colloids Surf B Biointerfaces; 2023 Jul; 227():113372. PubMed ID: 37257300 [TBL] [Abstract][Full Text] [Related]
49. The effect of increasing dialysate magnesium on calciprotein particles, inflammation and bone markers: post hoc analysis from a randomized controlled clinical trial. Bressendorff I; Hansen D; Pasch A; Holt SG; Schou M; Brandi L; Smith ER Nephrol Dial Transplant; 2021 Mar; 36(4):713-721. PubMed ID: 31764984 [TBL] [Abstract][Full Text] [Related]
50. The role of fetuin-A in physiological and pathological mineralization. Brylka L; Jahnen-Dechent W Calcif Tissue Int; 2013 Oct; 93(4):355-64. PubMed ID: 23277412 [TBL] [Abstract][Full Text] [Related]
51. Bisphosphonate FYB-931 Prevents High Phosphate-Induced Vascular Calcification in Rat Aortic Rings by Altering the Dynamics of the Transformation of Calciprotein Particles. Kawakami K; Ohya M; Yashiro M; Sonou T; Yamamoto S; Nakashima Y; Yano T; Tanaka Y; Ishida K; Kobashi S; Shigematsu T; Araki SI Calcif Tissue Int; 2023 Aug; 113(2):216-228. PubMed ID: 37099142 [TBL] [Abstract][Full Text] [Related]
52. Acute Tissue Mineral Deposition in Response to a Phosphate Pulse in Experimental CKD. Zelt JG; Svajger BA; Quinn K; Turner ME; Laverty KJ; Shum B; Holden RM; Adams MA J Bone Miner Res; 2019 Feb; 34(2):270-281. PubMed ID: 30216554 [TBL] [Abstract][Full Text] [Related]
53. Serum calcification propensity is associated with renal tissue oxygenation and resistive index in patients with arterial hypertension or chronic kidney disease. Pruijm M; Lu Y; Megdiche F; Piskunowicz M; Milani B; Stuber M; Bachtler M; Vogt B; Burnier M; Pasch A J Hypertens; 2017 Oct; 35(10):2044-2052. PubMed ID: 28562422 [TBL] [Abstract][Full Text] [Related]
54. Mineral and bone disorder and vascular calcification in patients with chronic kidney disease. Peres LA; Pércio PP J Bras Nefrol; 2014; 36(2):201-7. PubMed ID: 25055361 [TBL] [Abstract][Full Text] [Related]
55. [Vascular Calcification - Pathological Mechanism and Clinical Application - . Vascular calcification in chronic kidney disease-mineral and bone disorder (CKD-MBD)]. Omata M; Fukagawa M; Kakuta T Clin Calcium; 2015 May; 25(5):645-53. PubMed ID: 25926567 [TBL] [Abstract][Full Text] [Related]
56. Very low protein diet enhances inflammation, malnutrition, and vascular calcification in uremic rats. Yamada S; Tokumoto M; Tatsumoto N; Tsuruya K; Kitazono T; Ooboshi H Life Sci; 2016 Feb; 146():117-23. PubMed ID: 26764234 [TBL] [Abstract][Full Text] [Related]